GPCR
Structure Therapeutics Inc. American Depositary Shares
PHARMACEUTICAL PREPARATIONS
Best Pharmaceutical Stocks 2026 →
Structure Therapeutics (GPCR) Stock: Buy, Sell, or Hold?
$21.73
+0.32 (+1.49%)
â˛
5d:
+6.78%
30d:
-9.12%
90d:
-59.69%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (87%)
Quality Score
49/100
Position
FAIR
30-Day Fair Range
$20.27 â $25.00
Position: FAIR
Forward P/E & Valuation
-9.9x
Next 12M consensus est.
Wall Street Target
$107.29
+393.7% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$18.70 / $22.72
Trend: Strong Downtrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
âšī¸ NEUTRAL: GPCR is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
Get Alerted When GPCR Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: GPCR is currently trading at $21.73, which is considered fair relative to its 30-day fair value range of $20.27 to $25.00.
Technical Outlook: Technically, GPCR is in a strong downtrend. Immediate support is located at $18.70, while resistance sits at $22.72.
Market Sentiment: GPCR scores 70/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $107.29 (+393.7%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, GPCR is in a strong downtrend. Immediate support is located at $18.70, while resistance sits at $22.72.
Market Sentiment: GPCR scores 70/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $107.29 (+393.7%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$20.27 -
$25.00
Company Quality Score
49/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
86.8%
Trading Range & Key Levels
30-Day Trading Range
$20.27 -
$25.00
Current vs Trading Range
FAIR
Support Level
$18.70
Resistance Level
$22.72
Current Trend
Strong Downtrend
Technical data as of
Nov 10, 2026
Quantitative Signal Breakdown
- NEUTRAL: Price in fair range
- BULLISH: Strong technical setup (70/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 393.7% below Wall St target ($107.29)
- WARNING: Composite score 49/100 in the bottom quintile â this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
-9.94
Wall Street Target
$107.29
(+393.7%)
Share GPCR Analysis
Share this live GPCR analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (GPCR)
Bearish
1 Retail Mentions
Reddit / WSB Comments
1
Bearish
Last Tracked
Dec 9, 2025
Daily AI digest
AI Retail Discussion Summary:
Reddit & WallStreetBets discussions on GPCR are bearish (sentiment score +0.00) across 1 tracked comments.
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 11, 2026 8:16 AM ET
Data refreshes hourly during market hours. Next update: 9:16 AM
Data refreshes hourly during market hours. Next update: 9:16 AM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is GPCR showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
RVMD
Revolution Medicines Inc |
STRONG BUY
25 analysts |
$261 | 52 HOLD |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
21 analysts |
$95 | 42 HOLD |
|
JANX
Janux Therapeutics Inc |
STRONG BUY
18 analysts |
$32 | 46 HOLD |
|
CRNX
Crinetics PharmaceuticalâĻ |
STRONG BUY
17 analysts |
$86 | 46 HOLD |
|
ACHV
Achieve Life Sciences Inc |
STRONG BUY
12 analysts |
$14 | 56 HOLD |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive GPCR Research Pages
